Notice: file_put_contents(): Write of 8006 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50
Lymbo@碎碎念 | Telegram Webview: lymbo_chatting/5967 -
Telegram Group & Telegram Channel
Forwarded from 竹新社
瑞金医院普外科主任郑民华等20名上海市政协委员提案《关于在药品集采背景下如何能够用到疗效好的药物》:高血压糖尿病药物、肠镜泻药麻醉药集采后药效不佳,加大药量也不起效。希望放开国产仿制与进口原研药比例限制,把选择权交给医生;落实不良反应报告制度,及时报告疗效存疑的药物。
国家医保局去函上海医保局,要求其联系瑞金医院郑民华,代表国家局致谢并进一步了解具体品种,责成中选企业回应临床关切,确有质量问题的解除采购协议。
要求上海局举一反三,对于临床反映“集采中选药品降价后存在质量问题”的参照跟进,如存在严重质量问题的报药监。欢迎医务人员做药品价格和质量问题的吹哨人。
东方网健识局



tg-me.com/lymbo_chatting/5967
Create:
Last Update:

瑞金医院普外科主任郑民华等20名上海市政协委员提案《关于在药品集采背景下如何能够用到疗效好的药物》:高血压糖尿病药物、肠镜泻药麻醉药集采后药效不佳,加大药量也不起效。希望放开国产仿制与进口原研药比例限制,把选择权交给医生;落实不良反应报告制度,及时报告疗效存疑的药物。
国家医保局去函上海医保局,要求其联系瑞金医院郑民华,代表国家局致谢并进一步了解具体品种,责成中选企业回应临床关切,确有质量问题的解除采购协议。
要求上海局举一反三,对于临床反映“集采中选药品降价后存在质量问题”的参照跟进,如存在严重质量问题的报药监。欢迎医务人员做药品价格和质量问题的吹哨人。
东方网健识局

BY Lymbo@碎碎念


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/lymbo_chatting/5967

View MORE
Open in Telegram


Lymbo@碎碎念 Telegram | DID YOU KNOW?

Date: |

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

China’s stock markets are some of the largest in the world, with total market capitalization reaching RMB 79 trillion (US$12.2 trillion) in 2020. China’s stock markets are seen as a crucial tool for driving economic growth, in particular for financing the country’s rapidly growing high-tech sectors.Although traditionally closed off to overseas investors, China’s financial markets have gradually been loosening restrictions over the past couple of decades. At the same time, reforms have sought to make it easier for Chinese companies to list on onshore stock exchanges, and new programs have been launched in attempts to lure some of China’s most coveted overseas-listed companies back to the country.

Lymbo@碎碎念 from no


Telegram Lymbo@碎碎念
FROM USA